Podcasts · Talking Points

The VESALIUS-CV Trial

· 7:21

Episode The VESALIUS-CV Trial

0:00 7:21

Paul Burton and C. Michael Gibson discuss the effects of adding evolocumab for patients at high risk for CV events but without prior MI or stroke.

The episode on the publisher’s site (opens in a new tab)

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.